News of the WeekGene Therapy

RAC Hears a Plea for Resuming Trials, Despite Cancer Risk

See allHide authors and affiliations

Science  14 Feb 2003:
Vol. 299, Issue 5609, pp. 991
DOI: 10.1126/science.299.5609.991b

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


After learning more about the leukemias in two patients in a French gene-therapy trial, a U.S. review panel this week suggested that although it makes sense to keep this trial on hold, others might be allowed to resume. The panel also learned that a third patient in the French trial has a gene insertion like the one in the two who developed leukemia--although this child does not have leukemia.